CERIBELL INC. - COMMON STOCK

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference

20 5 2025 13:05:00 提供 Nasdaq GlobeNewswire

Ceribell Reports First Quarter 2025 Financial Results

08 5 2025 13:05:02 提供 Nasdaq GlobeNewswire

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

30 4 2025 13:05:00 提供 Nasdaq GlobeNewswire

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems

30 4 2025 05:00:00 提供 Nasdaq GlobeNewswire

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

24 4 2025 13:05:00 提供 Nasdaq GlobeNewswire

FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

15 4 2025 05:00:00 提供 Nasdaq GlobeNewswire

Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results

25 2 2025 13:05:00 提供 Nasdaq GlobeNewswire

Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference

18 2 2025 13:05:00 提供 Nasdaq GlobeNewswire

Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

11 2 2025 13:05:00 提供 Nasdaq GlobeNewswire

Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

23 12 2024 13:05:00 提供 Nasdaq GlobeNewswire

Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing

19 11 2024 05:00:00 提供 Nasdaq GlobeNewswire

Ceribell Reports Third Quarter 2024 Financial Results

12 11 2024 13:05:01 提供 Nasdaq GlobeNewswire

Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs

11 11 2024 05:00:00 提供 Nasdaq GlobeNewswire

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

07 11 2024 13:05:01 提供 Nasdaq GlobeNewswire